Condition: Epilepsy · Drug Resistant Epilepsy · Sponsor: Assistance Publique Hopitaux De Marseille
The goal of this clinical trial is to to obtain a significant decrease in seizure frequency in patients with refractory focal epilepsy after applying treatment of cathodal tDCS, compared to sham stimulation drug-resistant epileptic patient. The main questions it aims to answer are: * Changes in quality of life * Percent of newly reported side effects after the stimulation period * Scores in epilepsy severity. Participants will be randomized in a cross-over, and will receive 10 days of tDCS or Sham. Each day will allow 2 periods of 20 minutes stimulation separated by 20 minutes off (with 40 minutes of cathodal stimulation total).
This description comes directly from the study's public registry record.
Fabrice Bartolomei, MD, PhD · 0491384990 · fabrice.bartolomei@ap-hpm.fr
Sophie Tardoski · 0491381594 · sophie.tardoski@ap-hm.fr
Always discuss trial participation with your own doctor first.
| Service de Neurophysiologie Clinique de l'Enfant et de L'Adulte, Pôle de Neurosciences Cliniques | Bordeaux, France | Recruiting |
| Département Neurologie Fonctionnelle et Epilepsie, Hôpital neurologique - Hospices Civils de Lyon | Bron, France | Recruiting |
| Service de Neurophysiologie clinique - Hôpital Roger Salengro, CHU Lille | Lille, France | Not Yet Recruiting |
| Service Epileptologie et Rythmologie Cérébrale, Hôpital La Timone | Marseille, France | Recruiting |
| Service de Neurophysiologie clinique - GHU Psychiatrie et Neurosciences Sainte-Anne | Paris, France | Not Yet Recruiting |
| Service de Neurologie - CHU de Rennes - Hôpital Pontchaillou | Rennes, France | Not Yet Recruiting |
| Explorations neurophysiologiques - Pôle neurosciences, CHU de Toulouse, Hôpital Pierre Paul Riquet | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06334952